|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0039601,
umls-concept:C0194810,
umls-concept:C0202227,
umls-concept:C0332293,
umls-concept:C0376358,
umls-concept:C0392752,
umls-concept:C0523912,
umls-concept:C0681842,
umls-concept:C1306673,
umls-concept:C1521733,
umls-concept:C1550147
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-4-10
|
|
pubmed:abstractText |
In the last decade numerous groups have shown that low levels of pretreatment serum total testosterone consistently predict more aggressive disease, worse prognosis and worse treatment response in patients with metastatic prostate cancer. Prior studies have not demonstrated this same correlation in patients with known localized disease. We rigorously tested pretreatment total testosterone levels as a potential staging and prognostic marker in a large cohort of 879 patients with localized cancer treated with radical prostatectomy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
pubmed-author:AmlingChristopherC,
pubmed-author:ChungAndrewA,
pubmed-author:DonahueTimothyT,
pubmed-author:FoleyJohnJ,
pubmed-author:KusudaLeoL,
pubmed-author:LanceRaymondR,
pubmed-author:MassengillJason CJC,
pubmed-author:McLeodDavid GDG,
pubmed-author:MoulJudd WJW,
pubmed-author:SextonWadeW,
pubmed-author:SoderdahlDouglasD,
pubmed-author:SunLeonL,
pubmed-author:WuHongyuH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
169
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1670-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12686805-Aged,
pubmed-meshheading:12686805-Humans,
pubmed-meshheading:12686805-Male,
pubmed-meshheading:12686805-Middle Aged,
pubmed-meshheading:12686805-Neoplasm Recurrence, Local,
pubmed-meshheading:12686805-Neoplasm Staging,
pubmed-meshheading:12686805-Predictive Value of Tests,
pubmed-meshheading:12686805-Preoperative Care,
pubmed-meshheading:12686805-Prostate-Specific Antigen,
pubmed-meshheading:12686805-Prostatectomy,
pubmed-meshheading:12686805-Prostatic Neoplasms,
pubmed-meshheading:12686805-Retrospective Studies,
pubmed-meshheading:12686805-Testosterone
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.
|
|
pubmed:affiliation |
Department of Surgery, Center for Prostatic Disease Research, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
